Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus

The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women

(2013) Geeta Hampson et al.   BONE

Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus

(2013) Thomas Neumann et al.   CLINICAL ENDOCRINOLOGY

The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus

(2013) Agostino Gaudio et al.   Diabetes & Vascular Disease Research

Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels

(2013) S. Morales-Santana et al.   DIABETES CARE

Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus

(2013) Masahiro Yamamoto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sclerostin: Another Vascular Calcification Inhibitor?

(2013) Kathleen J. Claes et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?

(2013) L. Viaene et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids

(2013) B. García-Fontana et al.   OSTEOPOROSIS INTERNATIONAL

Wnt signalling in smooth muscle cells and its role in cardiovascular disorders

(2012) C. Mill et al.   CARDIOVASCULAR RESEARCH

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Female reproduction and type 1 diabetes: from mechanisms to clinical findings

(2012) E. Codner et al.   HUMAN REPRODUCTION UPDATE

High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study

(2012) Mohammed-Salleh M Ardawi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS study

(2012) Pawel Szulc et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes

(2012) Luigi Gennari et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults

(2011) Karin Amrein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells

(2011) Dongxing Zhu et al.   PLoS One

Sclerostin: Current Knowledge and Future Perspectives

(2010) M. J. C. Moester et al.   CALCIFIED TISSUE INTERNATIONAL

Wnt4/β-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening

(2010) Aikaterini Tsaousi et al.   CIRCULATION RESEARCH

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

(2010) Ulrike I Mödder et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women

(2010) Faryal S. Mirza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Proteomics Characterization of Extracellular Space Components in the Human Aorta

(2010) Athanasios Didangelos et al.   MOLECULAR & CELLULAR PROTEOMICS

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

Differences in Atherosclerotic Plaque Burden and Morphology Between Type 1 and 2 Diabetes as Assessed by Multislice Computed Tomography

(2009) R. Djaberi et al.   DIABETES CARE

Wnt5a is expressed in murine and human atherosclerotic lesions

(2008) Mark A. Christman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Osteoporosis among patients with type 1 and type 2 diabetes

(2008) A. Räkel et al.   DIABETES & METABOLISM

Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes

(2008) K. K. Danielson et al.   OSTEOPOROSIS INTERNATIONAL